Total syntheses of the bromotyrosine-derived natural products ianthelline, 5-bromoverongamine and JBIR-44

Tetrahedron Letters

Volumn 51, Issue 37, 2010, Pages 4812-4814

  Shearman, James W ^a   Myers, Rebecca M ^a   Beale, Thomas M ^a   Brenton, James D ^b   Ley, Steven V ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

5 Bromoverongamine; Anticancer; Bromotyrosine; Ianthelline; JBIR 44

Indexed keywords

5 BROMOVERONGAMINE; ANTINEOPLASTIC AGENT; BROMOTYROSINE; CERATAMINE A; CERATAMINE B; IANTHELLINE; JBIR 44; NATURAL PRODUCT; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOTHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; UMBILICAL VEIN; UTERINE CERVIX CANCER;

EID: 77955853392     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.07.016     Document Type: Article

References (41)

1. F. Hentschel, and T. Lindel Synthesis 2010 181 204
2. N. Fusetani, Y. Masuda, Y. Nakao, S. Matsunaga, and R.W.M. van Soest Tetrahedron 57 2001 7507 7511
3. A. Benharref, M. Païs, and C. Debitus J. Nat. Prod. 59 1996 177 180
4. A. Aiello, E. Fattorusso, M. Menna, and M. Pansini Biochem. Syst. Ecol. 23 1995 377 381
5. S. Albrizio, P. Ciminiello, E. Fattorusso, S. Magno, and M. Pansini Tetrahedron 50 1994 783 788
6. M.R. Kernan, R.C. Cambie, and P.R. Bergquist J. Nat. Prod. 53 1990 615 622
7. N. Pick, M. Rawat, D. Arad, J. Lang, J. Fan, A.S. Kende, and Y. Av-Gay J. Med. Microbiol. 55 2006 407 415
8. R.C. Schoenfeld, and B. Ganem Tetrahedron Lett. 39 1998 4147 4150
9. S. Tsukamoto, H. Kato, H. Hirota, and N. Fusetani Tetrahedron 52 1996 181 186
10. S. Ortlepp, M. Sjögren, M. Dahlström, H. Weber, R. Ebel, R. Edrada, C. Thoms, P. Schupp, L. Bohlin, and P. Proksch Marine Biotech. 9 2007 776 785
11. J.-H. Jang, R.W.M. van Soest, N. Fusetani, and S. Matsunaga J. Org. Chem. 72 2007 1211 1217
12. N. Takada, R. Watanabe, K. Suenaga, K. Yamada, K. Ueda, M. Kita, and D. Uemura Tetrahedron Lett. 42 2001 5265 5267
13. C.J. Hernández-Guerrero, E. Zubía, M.J. Ortega, and J. Luis Carballo Bioorg. Med. Chem. 15 2007 5275 5282
14. P.B. Shinde, Y.M. Lee, H.T. Dang, J. Hong, C.-O. Lee, and J.H. Jung Bioorg. Med. Chem. Lett. 18 2008 6414 6418
15. E. Manzo, R. van Soest, L. Matainaho, M. Roberge, and R.J. Andersen Org. Lett. 5 2003 4591 4594
16. G. Karjala, Q. Chan, E. Manzo, R.J. Andersen, and M. Roberge Cancer Res. 65 2005 3040 3043
17. R.S. Coleman, E.L. Campbell, and D.J. Carper Org. Lett. 11 2009 2133 2136
18. R. Córdoba, N. Salvador Tormo, A.F. Medarde, and J. Plumet Bioorg. Med. Chem. 15 2007 5300 5315
19. I.C. Piña, J.T. Gautschi, G.Y. Wang, M.L. Sanders, F.J. Schmitz, D. France, S. Cornell-Kennon, L.C. Sambucetti, S.W. Remiszewski, L.B. Perez, K.W. Bair, and P. Crews J. Org. Chem. 68 2003 3866 3873
20. M.S. Buchanan, A.R. Carroll, G.A. Fechner, A. Boyle, M. Simpson, R. Addepalli, V.M. Avery, J.N.A. Hooper, T.H.C. Cheung, and R.J. Quinn J. Nat. Prod. 71 2008 1066 1067
21. M. Litaudon, and M. Guyot Tetrahedron Lett. 27 1986 4455 4456
22. I. Thirionet, D. Daloze, J.C. Braekman, and P. Willemsen Nat. Prod. Lett. 12 1998 209 214
23. Kottakota, S. K.; Harburn, J. J.; O'Shaughnessy, A.; Gray, M.; Konstanidis, P.; Yakubu, D. E. 13th International Electronic Conference on Synthetic Organic Chemistry (ESOC-13), 1-30 November, 2009.
24. T. Fujiwara, J.H. Hwang, A. Kanamoto, H. Nagai, M. Takagi, and K. Shinya J. Antibiot. 62 2009 393 395
25. S. Nishiyama, and S. Yamamura Bull. Chem. Soc. Jpn. 1985 3453 3456
26. G. Zhu, F. Yang, R. Balachandran, P. Höök, R.B. Vallee, D.P. Curran, and B.W. Day J. Med. Chem. 49 2006 2063 2076
27. H.H. Wasserman, and J. Wang J. Org. Chem. 63 1998 5581 5586
28. J. García, R. Pereira, and A.R. de Lera Tetrahedron Lett. 50 2009 5028 5030
29. A.M. Godert, N. Angelino, A. Woloszynska-Read, S.R. Morey, S.R. James, A.R. Karpf, and J.R. Sufrin Bioorg. Med. Chem. Lett. 16 2006 3330 3333
30. N.T.R. Boehlow, J. Harburn, and C.D. Spilling J. Org. Chem. 66 2001 3111 3118
31. K.L. Bailey, and T.F. Molinski Tetrahedron Lett. 43 2002 9657 9661
32. K.J. Okamoto, and J. Clardy Tetrahedron Lett. 28 1987 4969 4972
33. E. Erlenmeyer Justus Liebigs Ann. Chem. 275 1893 1 8
34. Crystal data for 11: C12H9Br2NO3, M = 375.02, monoclinic, space group P2(1)/c, a = 11.5810(3) Å, b = 14.3132(3) Å, c = 7.6379(2) Å, V = 1261.35(8) Å3, Z = 4, Dc = 1.975 Mg m-3, T = 180(2) K. CCDC 778410
35. Prepared following the procedure described in Yang, F. Ph.D. Thesis, University of Pittsburgh, 2006.
36. Prepared following the procedure described in N. Ullah, and K.M. Arafeh Tetrahedron Lett. 50 2009 158 160
37. C 152.0) which we have assigned to C-8. The HMBC spectra for the natural sample are not available for direct comparison.
38. 13C NMR spectrum for the natural material was kindly provided by Professor Jean Claude Braekman for comparison and is included in the Supplementary data.
39. -3, T = 180(2) K. CCDC 777660.
40. The (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- sulfophenyl)-2H-tetrazolium) (MTS) assay gives a colourimetric measure of the number of viable cells present in vitro.
41. S. Rodríguez-Nieto, M. González-Iriarte, R. Carmona, R. Muñoz-Chápuli, M.A. Medina, and A.R. Quesada FASEB J. 16 2002 261 263